Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Effects of Radix Linderae extracts on a mouse model of diabetic bladder dysfunction in later decompensated phase. [electronic resource] by
- Yang, Xufeng
- Lian, Dawei
- Fan, Pinglong
- Xu, Yifei
- Wang, Jing
- Chen, Fangjun
- Lai, Huanling
- Jiang, Weiwen
- Zhang, Linjie
- Huang, Ping
- Cao, Hongying
Producer: 20190318
In:
BMC complementary and alternative medicine vol. 19
Availability: No items available.
|
|
9.
|
Artificial antigen-presenting cells are superior to dendritic cells at inducing antigen-specific cytotoxic T lymphocytes. [electronic resource] by
- Shao, Jie
- Xu, Qiuping
- Su, Shu
- Wei, Jia
- Meng, Fanyan
- Chen, Fangjun
- Zhao, Yang
- Du, Juan
- Zou, Zhengyun
- Qian, Xiaoping
- Liu, Baorui
Producer: 20190729
In:
Cellular immunology vol. 334
Availability: No items available.
|
|
10.
|
Activation and propagation of tumor-infiltrating lymphocytes from malignant pleural effusion and ascites with engineered cells for costimulatory enhancement. [electronic resource] by
- Xu, Qiuping
- Shao, Jie
- Su, Shu
- Wei, Jia
- Chen, Fangjun
- Meng, Fanyan
- Zhao, Yang
- Du, Juan
- Zou, Zhengyun
- Qian, Xiaoping
- Liu, Baorui
Producer: 20190701
In:
Cellular immunology vol. 331
Availability: No items available.
|
|
11.
|
A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay to profile 20 plasma steroids in endocrine disorders. [electronic resource] by
- Wang, Zhenxin
- Wang, Hao
- Peng, Yingfei
- Chen, Fangjun
- Zhao, Lin
- Li, Xiaomu
- Qin, Jiaqian
- Li, Qianqian
- Wang, Beili
- Pan, Baishen
- Guo, Wei
Producer: 20210804
In:
Clinical chemistry and laboratory medicine vol. 58
Availability: No items available.
|
|
12.
|
Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer. [electronic resource] by
- Yang, Ju
- Yan, Jing
- Shao, Jie
- Xu, Qiuping
- Meng, Fanyan
- Chen, Fangjun
- Ding, Naiqing
- Du, Shiyao
- Zhou, Shujuan
- Cai, Juan
- Wang, Qin
- Liu, Baorui
Publication details: OncoTargets and therapy 2019
In:
OncoTargets and therapy vol. 12
Availability: No items available.
|
|
13.
|
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein. [electronic resource] by
- Chen, Hong
- Sha, Huizi
- Zhang, Lianru
- Qian, Hanqing
- Chen, Fangjun
- Ding, Naiqin
- Ji, Liulian
- Zhu, Anqing
- Xu, Qiuping
- Meng, Fanyan
- Yu, Lixia
- Zhou, Yan
- Liu, Baorui
Producer: 20181029
In:
International journal of nanomedicine vol. 13
Availability: No items available.
|
|
14.
|
HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression. [electronic resource] by
- Ma, Jian
- Fan, Yanxin
- Feng, Tingting
- Chen, Fangjun
- Xu, Zhipeng
- Li, Suqing
- Lin, Qingfeng
- He, Xiaoting
- Shi, Weihong
- Liu, Yang
- Liu, Zhihua
- Zhu, Bin
- Cao, Xiufeng
Publication details: Oncotarget 10 2017
In:
Oncotarget vol. 8
Availability: No items available.
|
|
15.
|
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression. [electronic resource] by
- Ma, Jian
- Fan, Yanxin
- Feng, Tingting
- Chen, Fangjun
- Xu, Zhipeng
- Li, Suqing
- Lin, Qingfeng
- He, Xiaoting
- Shi, Weihong
- Liu, Yang
- Liu, Zhihua
- Zhu, Bin
- Cao, Xiufeng
Publication details: Oncotarget 05 2018
In:
Oncotarget vol. 9
Availability: No items available.
|
|
16.
|
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression. [electronic resource] by
- Ma, Jian
- Fan, Yanxin
- Feng, Tingting
- Chen, Fangjun
- Xu, Zhipeng
- Li, Suqing
- Lin, Qingfeng
- He, Xiaoting
- Shi, Weihong
- Liu, Yang
- Liu, Zhihua
- Zhu, Bin
- Cao, Xiufeng
Publication details: Oncotarget 03 2019
In:
Oncotarget vol. 10
Availability: No items available.
|
|
17.
|
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer. [electronic resource] by
- Ding, Naiqing
- Zou, Zhengyun
- Sha, Huizi
- Su, Shu
- Qian, Hanqing
- Meng, Fanyan
- Chen, Fangjun
- Du, Shiyao
- Zhou, Shujuan
- Chen, Hong
- Zhang, Lianru
- Yang, Ju
- Wei, Jia
- Liu, Baorui
Producer: 20190415
In:
Nature communications vol. 10
Availability: No items available.
|
|
18.
|
Bispecific tumor-penetrating protein anti-EGFR-iRGD efficiently enhances the infiltration of lymphocytes in gastric cancer. [electronic resource] by
- Zhu, Anqing
- Sha, Huizi
- Su, Shu
- Chen, Fangjun
- Wei, Jia
- Meng, Fanyan
- Yang, Yang
- Du, Juan
- Shao, Jie
- Ji, Fuzhi
- Zhou, Chong
- Zou, Zhengyun
- Qian, Xiaoping
- Liu, Baorui
Publication details: American journal of cancer research 2018
In:
American journal of cancer research vol. 8
Availability: No items available.
|
|
19.
|
CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. [electronic resource] by
- Su, Shu
- Zou, Zhengyun
- Chen, Fangjun
- Ding, Naiqing
- Du, Juan
- Shao, Jie
- Li, Lin
- Fu, Yao
- Hu, Bian
- Yang, Yang
- Sha, Huizi
- Meng, Fanyan
- Wei, Jia
- Huang, Xingxu
- Liu, Baorui
Publication details: Oncoimmunology
In:
Oncoimmunology vol. 6
Availability: No items available.
|
|
20.
|
CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. [electronic resource] by
- Su, Shu
- Hu, Bian
- Shao, Jie
- Shen, Bin
- Du, Juan
- Du, Yinan
- Zhou, Jiankui
- Yu, Lixia
- Zhang, Lianru
- Chen, Fangjun
- Sha, Huizi
- Cheng, Lei
- Meng, Fanyan
- Zou, Zhengyun
- Huang, Xingxu
- Liu, Baorui
Producer: 20170106
In:
Scientific reports vol. 6
Availability: No items available.
|